Le Lézard
Classified in: Health
Subjects: RCL, PSF, CFG

Food Recall Warning - Red Chili Ingredient included in certain Hello Fresh brand and Chefs Plate brand Meal Kits recalled due to Salmonella


Product photos are available at https://bit.ly/2U1EQSC

OTTAWA, Jan. 21, 2019 /CNW/ - Hello Fresh Canada Inc. is recalling the red chili ingredient included in certain Hello Fresh brand and Chefs Plate brand meal kits from the marketplace due to possible Salmonella contamination of that ingredient. Consumers should not consume the recalled products described below.

The following products have been sold in Manitoba, Ontario, Quebec, New Brunswick, Nova Scotia, Prince Edward Island, and Newfoundland and Labrador.

Recalled products

 

Brand

Product

Size

UPC

Codes

Hello Fresh

Red chili

1

(included in the 902 g kit)

None

Included in Hello Fresh brand Coconut Dal meal kit coded as

Best Before 19 JA 29

WK19041920

2P

Hello Fresh

Red chili

1

(included in the 1804 g kit)

None

Included in Hello Fresh brand Coconut Dal meal kit coded as

Best Before 19 JA 29

WK19041920
4P

Chefs Plate

Red chili

1

(included in the 856 g kit)

None

Included in Chefs Plate brand Beef Chow Mein meal kit coded as January 19, 2019 (A2)

 

Chefs Plate

Red chili

1

(included in the 856 g kit)

None

Included in Chefs Plate brand Beef Chow Mein meal kit coded as January 22, 2019 (A2)

 

Chefs Plate

Red chili

1

(included in the 1712 g kit)

None

Included in Chefs Plate brand Beef Chow Mein meal kit coded as January 19, 2019 (A4)

 

Chefs Plate

Red chili

1

(included in the 1712 g kit)

None

Included in Chefs Plate brand Beef Chow Mein meal kit coded as January 22, 2019 (A4)

 

 

What you should do

If you think you became sick from consuming a recalled product, call your doctor.

Check to see if you have recalled products in your home. Recalled products should be thrown out or returned to the store where they were purchased.

Food contaminated with Salmonella may not look or smell spoiled but can still make you sick. Young children, pregnant women, the elderly and people with weakened immune systems may contract serious and sometimes deadly infections. Healthy people may experience short-term symptoms such as fever, headache, vomiting, nausea, abdominal cramps and diarrhea. Long-term complications may include severe arthritis.

Background

This recall was triggered by the company. The Canadian Food Inspection Agency (CFIA) is conducting a food safety investigation, which may lead to the recall of other products. If other high-risk products are recalled, the CFIA will notify the public through updated Food Recall Warnings.

The CFIA is verifying that industry is removing recalled product from the marketplace.

Illnesses

There have been no reported illnesses associated with the consumption of these products.

More information

 

SOURCE Canadian Food Inspection Agency (CFIA)


These press releases may also interest you

at 12:20
The "Regenerative Medicine Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering. Regenerative Medicine Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented...

at 12:10
The "Diagnostic Imaging Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering. Diagnostic Imaging Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to...

at 12:05
King Faisal Specialist Hospital & Research Centre (KFSH&RC) has achieved a significant milestone in its Robotic Cardiac Surgery Program, which was initiated in February 2019. Within its first year, the program performed 105 cardiac procedures. As of...

at 11:55
The "Infectious Vaccine Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering. Infectious Vaccine Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to...

at 11:40
The "Musculoskeletal Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering. Musculoskeletal Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the...

at 11:30
The "Option and Evaluation Deals in Pharmaceuticals and Biotechnology 2016-2024" report has been added to ResearchAndMarkets.com's offering. Fully revised and updated, the report provides details of option and evaluation deals from 2016 to 2024....



News published on and distributed by: